anaphylaxi
repres
nonatop
immedi
hypersensit
wherea
manifest
atop
immedi
hypersensit
includ
bronchial
asthma
hay
fever
allerg
rhiniti
chronic
urticaria
atop
dermat
spite
similar
antigen
exposur
minor
popula
chapter
describ
immun
pharmacolog
mechan
associ
viral
infect
certain
immunolog
diseas
belong
group
socal
immedi
hypersensit
term
immedi
hypersensit
denot
immunolog
sensit
antigen
manifest
tissu
reaction
occur
within
minut
antigen
combin
appropri
antibodi
reaction
may
occur
member
speci
non
atop
immedi
hypersensit
certain
predispos
hyperreact
member
atop
immedi
hypersensit
popul
natur
constitut
basi
atopi
underli
determin
develop
atop
diseas
yet
unexplain
mani
theori
constitut
basi
atopi
propos
sinc
coca
cook
origin
definit
two
gener
idea
howev
surviv
percept
atopi
primari
disord
immun
system
sequela
variou
effector
tissu
concept
atopi
primari
autonom
imbal
essenti
beta
adrenerg
charact
sequela
effector
cell
includ
engag
product
antibodi
autonom
imbal
perceiv
caus
disord
autonom
nervou
system
defector
function
effector
cell
two
concept
mutual
exclus
fact
may
interdepend
although
immun
featur
atop
diseas
understood
within
framework
basic
adrenerg
disord
variou
effector
cell
mani
nonimmun
featur
atop
condit
readili
explic
basi
primari
immun
abnorm
time
origin
concept
atopi
develop
long
known
hay
fever
asthma
often
occur
togeth
individu
show
mark
famili
tendenc
similarli
recogn
acut
chronic
urticaria
well
gastrointestin
manifest
idiosyncrasi
specif
food
common
patient
diseas
gener
popul
relat
infantil
eczema
besnier
prurigo
neurodermat
also
observ
eczema
found
occur
frequent
children
patient
hay
fever
asthma
individu
eczema
infanc
show
usual
incid
hay
fever
asthma
later
life
diseas
therefor
consid
togeth
cook
vander
veer
special
group
diseas
human
sensit
hereditari
background
author
conclud
sensit
individu
transmit
offspr
specif
sensit
unusu
capac
develop
bioplast
reactiv
foreign
protein
progress
determin
addit
characterist
human
sensit
contrast
experiment
anaphylaxi
laboratori
anim
coca
cook
conclud
clear
distinct
must
made
two
type
hypersensit
manifest
anaphylact
type
allerg
respons
abnorm
substanc
atop
type
respons
substanc
gener
innocu
state
latter
subgroup
evid
need
special
term
may
conveni
design
need
satisfactorili
met
term
atopi
kindli
suggest
professor
edward
perri
columbia
univers
greek
word
term
deriv
use
sens
strang
diseas
howev
account
necessari
includ
term
strang
diseas
use
term
restrict
hay
fever
asthma
group
wise
sulzberg
ad
neurodermat
new
design
atop
dermat
base
close
associ
condit
atop
manifest
wise
sulzberg
conclud
skin
lesion
disord
cutan
analog
hay
fever
asthma
suggest
name
atop
dermat
replac
dissemin
neurodermat
sever
characterist
atop
state
emerg
earli
concept
atopi
felt
hereditari
manifest
subject
domin
gene
peculiarli
human
disord
react
serum
element
differ
classic
antibodi
reminisc
wasserman
eagin
henc
name
atop
reagin
atop
antibodi
furthermor
seem
occur
n
human
mani
time
without
demonstr
prior
exposur
incit
substanc
nduce
agent
often
appear
nonantigen
atopen
grove
coca
year
postul
differ
atopi
anaphylaxi
radual
elimin
thu
ishizaka
discov
antibodi
essenti
ident
ltopic
reagin
variou
anim
speci
moreov
atop
diseas
shown
patterson
ccur
anim
distinct
anaphylaxi
atopi
also
amen
variou
altern
explan
indic
condit
may
separ
wide
irreconcil
differ
origin
concept
atopi
believ
qevertheless
differ
remain
import
new
differ
remain
ew
differ
emerg
make
imper
concept
atopi
reformul
inc
becom
increasingli
evid
addit
remain
mmunolog
differ
anaphylaxi
immedi
hypersensit
atop
lnd
nonatop
type
thu
appear
anaphylaxi
deal
normal
physiolog
antibodi
respons
unnatur
exposur
antigen
wherea
atop
allerg
abnorm
antibodi
respons
natur
antigen
exposur
seem
involv
anaphylact
eactiv
sensit
individu
depend
releas
amount
pharmacolog
lctive
effector
molecul
suffici
toxic
member
speci
confast
individu
atop
diseas
possess
quantit
qualit
abnorm
reactivti
otherwis
nontox
concentr
endogen
releas
exogen
administ
harmacolog
mediat
furthermor
quantit
chang
consist
direct
f
decreas
respons
betaadrenerg
agent
agonist
consist
tirect
increas
respons
one
pharmacolog
activ
effector
nolecul
involv
anoth
essenti
differ
atop
nonatop
varieti
immedi
hyperensit
major
contributori
role
play
infect
atopi
wherea
infect
ot
shown
causal
relat
anaphylact
allergi
anaphylaxi
arthu
reaction
r
serum
sick
moreov
atop
condit
precipit
number
unrel
timuli
wherea
specif
antigen
bring
anaphylaxi
final
latter
condiion
may
produc
artifici
atop
diseas
spontan
pattern
famili
ccurrenc
induc
acut
human
pulmonari
anaphylaxi
includ
tsthmatic
featur
exampl
never
report
lead
develop
bronchial
tsthma
atop
diseas
reformul
origin
concept
atopi
szentivanyi
l
essenti
differnc
immedi
hypersensit
nonatop
atop
varieti
ormer
condit
mediat
normal
immun
pharmacolog
mechan
wherea
ttopi
base
abnorm
immun
pharmacolog
mechan
differ
maphylaxi
atopi
regard
fundament
view
furthermor
alter
harmacolog
reactiv
consid
uniformli
present
singl
atop
characteris
pathognomon
signific
develop
betaadrenerg
approach
studi
constitut
basi
atopi
authent
atopi
produc
anim
human
neither
induc
directli
transfer
passiv
addit
anim
model
anaphylaxi
number
experiment
model
simul
human
atopi
well
isol
system
suitabl
studi
segment
area
atop
reactiv
use
analysi
individu
event
ie
mediat
releas
human
reaction
nevertheless
vivo
vitro
model
anaphylact
variant
repres
immunolog
pharmacolog
normal
reactiv
therefor
use
studi
constitut
abnorm
atopi
search
laboratori
model
guid
premis
meaning
model
must
abl
imit
immunolog
also
pharmacolog
abnorm
atop
state
latter
manifest
substanc
mammalian
physiolog
serv
natur
chemic
organ
autonom
action
seem
like
therefor
abnorm
reactiv
agent
could
effect
produc
alter
normal
autonom
regul
signific
enough
result
autonom
imbal
hypothalam
imbalanc
anaphylact
guinea
pig
first
attempt
establish
meaning
experiment
counterpart
atop
state
made
filip
szentivanyi
year
studi
hypothalam
imbalanc
anaphylact
guinea
pig
briefli
electrolyt
remov
one
hypothalam
divis
electr
stimul
antagonist
divis
possibl
alter
profoundli
anaphylact
reactiv
guinea
pig
immunolog
pharmacolog
immunolog
pharmacolog
standpoint
condit
produc
close
approxim
human
atop
state
anaphylaxi
nevertheless
felt
artifici
surgic
induc
hypothalam
imbal
far
remov
natur
set
involv
variou
inherit
acquir
factor
may
surround
develop
atop
state
effort
discov
accur
represent
natur
occur
condit
ie
infect
may
conceiv
serv
development
background
atopi
szentivanyi
fishel
earli
found
bordetella
pertussisinduc
hypersensit
state
serv
appropri
model
inject
live
kill
bordetella
pertussi
organ
certain
strain
mice
rat
modifi
normal
reaction
anim
number
variou
stimuli
possibl
applic
result
investig
atopi
impli
follow
princip
featur
b
pertussi
induc
alter
respons
l
hypersensit
endogen
releas
exogen
administ
histamin
serotonin
bradykinin
slowreact
substanc
prostaglandin
least
two
strain
acetylcholin
hypersensit
less
specif
stimuli
cold
chang
atmospher
pressur
respiratori
irrit
contrast
increas
sensit
reduc
beta
adrenerg
sensit
catecholamin
concern
metabol
paramet
revers
normal
betaadrenerg
activ
enhanc
antibodi
format
gener
adjuv
activ
facilit
product
quantiti
antibodi
ige
class
presenc
mark
eosinophilia
describ
szentivanyi
major
advanc
experi
pave
way
meaning
analog
atop
disord
find
hypersensit
pertussissensit
mous
pharmacolog
mediat
may
due
acquir
genet
determin
autonom
imbal
caus
primarili
reduc
function
adenyl
cyclas
coupl
beta
adrenerg
receptor
associ
cyclic
amp
system
theori
regard
disord
ie
perenni
season
allerg
rhiniti
bronchial
asthma
atop
dermat
immunolog
diseas
uniqu
pattern
alter
reactiv
broad
spectrum
immunolog
psychic
infecti
chemic
physic
stimuli
view
give
antigenantibodi
interact
role
broad
categori
nonspecif
stimuli
function
trigger
defect
homeostat
mechan
variou
effector
cell
biochem
reaction
sequenc
immedi
hypersensit
activ
defect
mechan
broad
spectrum
unrel
stimuli
believ
made
possibl
unusu
charact
pharmacolog
mediat
biolog
distinct
class
natur
substanc
mediat
view
standpoint
probabl
physiolog
function
chemic
organ
autonom
action
well
immunoregul
homeostat
control
consequ
regardless
immunolog
nonimmunolog
natur
trigger
event
chemic
realiz
would
expect
brought
essenti
mediat
homeostat
adjust
influenc
requir
among
thing
mobil
adrenerg
neurotransmitt
balanc
uninhibit
interact
effector
system
theori
postul
constitut
basi
atopi
lie
reduc
function
beta
adrenerg
effector
system
irrespect
trigger
event
may
chemic
particular
case
eg
immunolog
infecti
psychic
situat
adrenerg
neurotransmitt
releas
face
rel
unrespons
betaadrenerg
effector
system
result
autonom
imbal
depriv
effector
tissu
normal
counter
regulatori
adjust
constel
mediat
effector
lead
uniqu
pattern
quantit
qualit
alter
reactiv
chemic
organ
autonom
action
mostli
respons
trivial
trauma
theoret
scheme
appli
respiratori
cutan
atopi
least
six
level
respons
critic
diseas
expect
influenc
betaadrenerg
sub
sensit
question
reduct
normal
beta
adrenerg
inhibit
lysosom
enzym
releas
chemotaxi
phagocytosi
antibodi
depend
cellular
cytotox
increas
express
fc
ige
receptor
prostaglandin
e
synthesi
stimul
histamineinduc
suppressor
factor
effector
mechan
known
play
import
role
immunolog
inflamm
reduct
lymphocyt
betaadrenerg
sensit
result
abnorm
decreas
lymphocyt
transform
erosett
form
cell
cell
suppressor
cell
function
abnorm
increas
igeproduc
b
cell
fc
receptorbear
lymphocyt
lymphocyt
reactiv
mast
cell
mediat
releas
immunolog
nonimmunolog
stimuli
ordinarili
suppress
betaadrenerg
stimul
would
becom
sub
sensit
cholinerg
alphaadrenerg
enhanc
mediat
releas
would
exagger
betaadrenerg
mediat
bronchial
smooth
muscl
dilat
reduc
cholinerg
alphaadrenerg
mediat
constrict
augment
increas
mucou
secret
respons
alpha
adrenerg
cholinerg
stimul
sodium
water
flux
tracheobronchi
secret
respons
betaadrenerg
stimul
would
reduc
beta
adrenerg
mediat
eosinopenia
would
reduc
replac
eosinophilia
theoret
predict
manifest
fact
exist
repres
cardin
featur
atop
diseas
similarli
point
critic
malfunct
effectot
system
adenyl
cyclasecoupl
betaadrenerg
receptor
associ
cyclic
nucleotid
complex
follow
therefor
fundament
abnorm
common
atop
person
may
lie
inherit
acquir
lesion
caus
defect
function
intracellular
messeng
system
reduc
respons
catecholamin
would
reflect
alter
number
site
includ
chang
affin
catecholamin
receptor
site
decreas
number
reactiv
beta
receptor
interconvers
adrenerg
receptor
beta
alpha
alter
effici
coupl
activ
receptor
catalyt
unit
adenyl
cyclas
reduct
concentr
adenyl
cyclas
altern
postul
lesion
may
occur
point
beyond
camp
gener
step
biolog
sequenc
lead
adrenerg
end
respons
camp
relat
pathway
complementari
interact
modul
system
provid
acetylcholin
histamin
prostaglandin
leukotrien
interleukin
larg
group
lymphokin
monokin
cytokin
intracellular
messeng
system
counter
regulatori
potenti
associ
cyclic
gmp
current
avail
evid
seem
favor
possibl
inherit
andor
acquir
multipl
abnorm
receptoradenyl
yclasecycl
amp
system
essenti
effector
cell
critic
organ
immun
reactiv
progress
diseas
process
subclin
clinic
form
conceiv
requir
oper
preparatori
trigger
factor
preparatori
factor
involv
postul
abnorm
may
famili
presum
hereditari
acquir
natur
howev
either
case
must
set
stage
function
imbal
trigger
event
must
appropri
result
increas
rate
fire
adrenerg
neuron
conceiv
mediat
constel
suitabl
make
latent
abnorm
clinic
manifest
howev
preparatori
trigger
factor
need
separ
unrel
entiti
infect
probabl
viral
exampl
could
serv
capac
except
nonnucl
erythrocyt
adenyl
cyclas
system
found
anim
cell
examin
date
ubiquit
charact
suggest
ultim
clinic
manifest
fundament
atop
abnorm
determin
type
cell
primarili
involv
effector
cell
system
primarili
harbor
postul
abnorm
cell
bronchial
tissu
versu
nasal
mucosa
skin
circul
cell
blood
extens
analysi
experiment
evid
support
valid
betaadrenerg
theori
atop
disord
updat
formul
reader
refer
major
review
respect
appar
central
featur
atop
abnorm
betaadrenerg
subsensit
effector
cell
particip
cellular
organ
atop
respons
question
could
rais
abnorm
could
develop
present
least
three
major
development
mechan
envisag
abnorm
may
l
acquir
function
receptor
regulatori
shift
caus
hormon
chang
infect
viral
bacteri
etc
allerg
tissu
injuri
event
genet
determin
caus
autoimmun
diseas
case
given
atop
disord
one
two
three
effector
mechan
may
oper
orient
chapter
role
viral
infect
allerg
tissu
injuri
autoimmun
due
antireceptor
antibodi
discuss
upper
respiratori
tract
infect
frequent
shown
precipit
exacerb
asthmat
condit
produc
increas
airway
hyperreact
bronchospast
agent
earlier
era
whoop
cough
common
bordetella
pertussi
infect
consid
frequent
caus
asthma
recurr
bronchospasm
even
today
evid
hemophilu
influenza
infect
present
deeper
respiratori
tract
asthmat
patient
sinc
bacterium
shown
produc
anim
experi
beta
adrenerg
impair
andor
increas
cyclic
gmp
level
relationship
h
influenza
infect
pharmacolog
abnorm
asthma
may
authent
one
meantim
contrast
bacteri
pathogen
viral
respiratori
infect
shown
signific
role
pathogenesi
asthma
asian
pandem
late
sever
exacerb
bronchial
asthma
found
among
frequent
complic
infect
sinc
numer
report
appear
describ
import
relationship
asthma
viral
respiratori
infect
recent
refin
epidemiolog
method
microbiolog
isol
techniqu
pulmonari
function
test
provid
new
opportun
character
relationship
precis
review
avail
inform
indic
experi
anim
model
observ
children
suggest
express
atopi
occur
period
term
allerg
breakthrough
may
follow
viral
infect
histori
childhood
viral
iratori
ill
risk
factor
develop
chronic
obstruct
airway
syndrom
ter
life
infect
lead
obstruct
airway
diseas
result
manifest
keli
wheezi
asthmat
type
obstruct
airway
diseas
viral
oppos
acteri
respiratori
pathogen
commonli
herald
onset
wheez
childhood
preispos
develop
atopi
although
bronchial
pharmacolog
hyperreact
iral
ill
may
also
proceed
independ
immunolog
mechan
bronchospasm
inal
matter
ultim
effect
respiratori
infect
infanc
subsequ
evelop
asthma
may
littl
doubt
respiratori
virus
commonli
induc
xacerb
bronchospasm
older
child
adult
known
asthma
signific
one
anoth
respiratori
viru
caus
asthma
exacerb
ppear
depend
age
patient
thu
preschool
age
year
predomin
gent
respiratori
syncyti
viru
follow
parainfluenza
type
influenza
rhinoviru
nd
corona
viru
school
age
year
rhinoviru
lead
list
follow
descendg
order
incid
influenza
parainfluenza
type
respiratori
syncyti
viru
dult
order
rel
signific
chang
domin
influenza
viru
llow
rhinoviru
respiratori
syncyti
viru
anoth
dimens
viral
influenc
involv
problem
bronchial
hyperact
labil
asthma
recogn
time
normal
subject
exhibit
rel
short
red
bronchial
hyperirrit
inhal
histamin
viral
respiratori
infecon
state
asthma
may
worsen
viral
respiratori
infect
ome
situat
document
releas
airway
resist
could
partial
fulli
lock
atropin
aerosol
prompt
hypothesi
damag
epitheli
surfac
ae
upper
airway
viral
infect
expos
therebi
sensit
rapidli
adapt
sensori
titant
receptor
upper
airway
variou
inhal
irrit
caus
reflex
parasympathet
agal
bronchoconstrict
howev
sever
consider
discount
signific
parasympatheti
orient
interpret
viru
induc
asthmogenec
virus
implic
phenomenon
instanc
adenovirus
herp
viru
homini
influenza
type
b
viru
enterovirus
show
relationship
episod
asthma
studi
rhinoviru
suggest
rhinoviru
subtyp
associ
asthmogen
find
difficult
reconcil
damag
epithelium
hypothesi
assum
equival
infect
rais
question
possibl
mechan
relat
biochem
properti
viru
convers
influenza
type
viru
clearli
associ
increas
asthma
affect
lung
function
larg
effect
small
way
wherea
aforement
rapidli
adapt
sensori
irrit
receptor
primarili
distribut
larger
upper
airway
hypothesi
cholinerg
hyperact
consequ
epitheli
damag
presuppos
de
facto
presenc
activ
viral
infect
caus
respiratori
inflamm
lead
disrupt
airway
epitheli
barrier
activ
subepitheli
rapidli
adapt
sensori
irrit
receptor
inde
characterist
histolog
find
viral
respiratori
infect
epitheli
destruct
welliv
et
al
shown
ige
bound
exfoli
nasopharyng
epitheli
cell
patient
acut
phase
infect
respiratori
syncyti
viru
also
found
continu
presenc
cell
bound
ige
common
patient
bronchiol
asthma
mild
upper
respiratori
tract
infect
regard
establish
avian
speci
experiment
induc
viral
laryngotrach
result
disrupt
airway
epithelium
result
increas
permeat
horseradish
peroxidas
possibl
increas
uptak
inhal
antigen
furthermor
ida
associ
demonstr
interferon
elabor
viral
infect
leukocyt
harvest
patient
ragwe
allergi
may
induc
histamin
releas
suggest
atop
patient
may
experi
bronchial
hyperreact
specif
antigen
exposur
occur
time
viral
infect
circumst
import
mention
evid
avail
actual
respiratori
infect
influenza
type
viru
necessari
condit
develop
increas
airway
irrit
patient
asthma
thu
administr
kill
influenza
viru
vaccin
asthmat
patient
caus
signific
increas
bronchial
sensit
methacholin
aerosol
reach
maximum
one
day
persist
three
day
normal
subject
develop
heighten
respons
methacholin
evid
allergi
vaccin
detect
investig
suggest
effect
might
explain
endotoxinlik
action
influenza
vaccin
inde
endotoxin
sensit
human
bronchial
smooth
muscl
alphaadrenerg
agonist
report
phenylephrineinduc
contract
enhanc
two
ten
time
normal
lung
time
lung
patient
chronic
bronchiti
endotoxin
also
caus
decreas
cyclic
amp
tissu
observ
complement
recent
find
obtain
vaccin
purifi
lp
prepar
e
coli
result
decreas
number
betaadrenerg
receptor
guinea
pig
lung
observ
call
question
requir
activ
viral
infect
product
bronchial
hyperact
mediat
cholinerg
activ
irrit
receptor
thu
pulmonari
function
abnorm
adult
viral
respiratori
ill
gener
pronounc
seven
ten
day
onset
symptom
time
clinic
manifest
manifest
viral
inflamm
wane
also
abnorm
pulmonari
function
gener
prolong
well
beyond
recogn
period
viral
shed
furthermor
administr
antivir
agent
amantadin
hydrochlorid
although
clinic
effect
effect
magnitud
durat
airway
hyperact
one
longitudin
studi
minor
et
al
found
simpl
colon
respiratori
tract
viru
suffici
provok
asthma
attack
occur
infect
produc
symptom
fever
malais
cough
coryza
domin
role
fever
episod
immedi
suggest
profound
involv
adrenerg
effector
mechan
addit
support
import
effect
viral
infect
adrenerg
mechan
asthmat
patient
came
extens
studi
buss
associ
experi
human
granulocyt
serv
conveni
vitro
model
systemat
studi
viru
incub
pharmacolog
agonist
respons
first
describ
impair
inhibitori
action
beta
adrenerg
agonist
isoproterenol
normal
observ
lysosom
enzym
releas
occur
granulocyt
taken
asthmat
patient
lysosom
enzym
known
play
major
role
bronchial
immunolog
inflamm
beta
adrenerg
impair
lysosom
enzym
releas
significantli
greater
cell
obtain
upper
respiratori
infect
follow
observ
buss
colleagu
consist
report
virusinduc
impair
sever
neutrophil
mechan
normal
mediat
inhibit
enzym
releas
impair
occur
incub
vitro
live
influenza
viru
live
rhinoviru
rv
find
also
observ
follow
infect
normal
subject
rv
studi
report
impair
normal
function
beta
adrenerg
histamin
h
pge
receptor
respons
inhibit
lysosom
enzym
releas
stimul
adenyl
cyclas
result
cyclic
amp
format
interfer
granulocyt
betaadrenerg
receptor
activ
influenza
viru
subsequ
confirm
lee
extend
includ
lymphocyt
result
decreas
inhibit
erosett
format
betaadrenerg
stimul
isoproterenol
anoth
import
studi
buckner
et
al
show
parainfluenza
infect
vivo
caus
select
blockad
betaadrenerg
inhibit
antigen
induc
contract
isol
airway
smooth
muscl
abnorm
moreov
limit
known
atopi
may
also
demonstr
cell
system
normal
subject
viral
infect
therefor
may
import
inhibitori
effect
betaadrenerg
respons
cours
bronchoconstrict
area
recent
extens
review
norri
eyr
point
analysi
evid
parasympatheticlli
cholinerg
orient
viru
induc
asthmogenec
includ
argument
base
inform
obtain
current
state
understand
aspect
virolog
immunolog
immunolog
inflamm
cyclic
nucleotid
system
discuss
argument
extend
includ
basic
principl
neurophysiolog
neuropharmacolog
also
contradict
basic
valid
hypothesi
nadel
associ
purpos
establish
appropri
framework
discuss
basic
tenet
hypothesi
restat
follow
past
two
decad
nadel
boushey
holtzman
associ
accumul
evid
indic
stimul
rapidli
adapt
epitheli
nerv
receptor
airway
mechan
chemic
pharmacolog
stimuli
reflexli
increas
output
acetylcholin
vagu
nerv
caus
reflex
bronchoconstrict
particular
shown
although
histamin
capabl
constrict
airway
smooth
muscl
directli
bronchoconstrictor
effect
vivo
indirect
due
reflex
mechan
accomplish
direct
stimul
epitheli
receptor
also
decreas
fire
threshold
introduc
stimuli
thu
histamin
inject
dog
bronchial
arteri
airway
constrict
block
atropin
otherwis
healthi
subject
viral
upper
respiratori
tract
infect
damag
bronchial
epithelium
caus
transient
bronchial
hyperact
inhal
histamin
citric
acid
phenomenon
also
abolish
anticholinerg
drug
basi
similar
observ
well
fact
bronchial
hyperact
associ
decreas
cough
threshold
worker
suggest
airway
epitheli
damag
sensit
airway
nerv
end
caus
exagger
cough
bronchomotor
respons
background
nadel
boushey
holtzman
associ
postul
bronchial
asthma
constel
involv
two
ingredi
releas
pharmacolog
mediat
sensit
airway
epitheli
nerv
receptor
provid
posit
feedback
system
increas
bronchomotor
tone
mechan
fact
probabl
contribut
bronchial
obstruct
process
asthma
alter
pharmacolog
reactiv
atopi
howev
restrict
airway
epitheli
effectot
univers
atop
trait
fact
explain
earlier
alter
pharmacolog
reactiv
uniformli
present
singl
atop
characterist
natur
must
explain
theori
attempt
elucid
constitut
basi
atopi
reason
cholinerg
overact
serv
capac
use
spontan
breath
unanesthet
guinea
pig
found
vagal
reflex
compon
histamin
bronchoconstrict
small
probabl
consequ
rather
caus
constrict
histaminesensit
histamineinsensit
strain
guinea
pig
demonstr
eas
vivo
histamineinduc
reduct
lung
complianc
guinea
pig
invers
relat
vitro
tracheal
sensit
isoproterenol
reveal
primari
homeostat
import
tracheobronchi
betaadrenerg
receptor
rather
cholinerg
control
determin
sensit
effector
tissu
histamin
harmoni
find
extens
studi
carri
human
past
year
recent
find
obyrn
et
al
support
conclus
long
seri
observ
indic
blockad
muscarin
cholinerg
receptor
small
effect
respons
inhal
histamin
also
observ
blockad
elicit
minor
degre
protect
respons
inhal
allergen
exercis
inhal
cold
air
subject
asthma
taken
togeth
experi
indic
bronchial
effect
histamin
exert
reflex
bronchoconstrict
stimul
h
receptor
airway
smooth
muscl
therefor
hyperrespons
histamin
asthma
primarili
caus
defect
parasympathet
nervou
suppli
airway
furthermor
reproduc
evid
elev
level
acetylcholin
tissu
bodi
fluid
atop
individu
avail
fact
surpris
issu
cholinerg
overact
examin
broader
biolog
context
gener
natur
cholinerg
versu
adrenerg
control
thu
sympathet
system
distribut
effector
bodi
wherea
parasympathet
distribut
much
limit
instanc
ympathet
postganglion
fiber
also
innerv
smooth
muscl
gland
somat
non
viscer
region
compar
distribut
establish
parasympathet
divis
moreov
sympathet
fiber
ramifi
much
greater
extent
preganglion
eermin
make
contact
larg
number
postganglion
neuron
gener
ratio
reganglion
postganglion
axon
may
addit
overlap
synapt
innerv
one
ganglion
cell
suppli
sever
preganglion
fiber
contrast
parasympathet
discret
action
ie
closer
lo
relat
preand
postganglion
neuron
also
parasympathet
system
reinforc
mechan
compar
adren
medulla
sympathet
divis
usual
part
sympathet
nervou
system
stimul
entir
system
least
major
portion
stimul
time
phenomenon
call
mass
discharg
norepinephrin
epinephrin
therefor
almost
alway
releas
adren
medulla
time
differ
tissu
stimul
directli
sympathet
nerv
fhe
two
mean
stimul
support
either
actual
substitut
without
stimul
howev
normal
rest
rate
secret
adren
medulla
suffici
maintain
blood
pressur
almost
normal
even
direct
sympathet
pathway
cardiovascular
system
remov
anoth
import
valu
adren
medulla
capabl
catecholamin
stimul
structur
bodi
innerv
sympathet
fiber
contrast
characterist
parasympathet
reflex
discret
instanc
usual
act
heart
increas
decreas
activ
frequent
caus
secret
mouth
instanc
secret
stomach
gland
acetylcholin
ach
ie
cholinerg
transmitt
releas
parasympathet
fiber
almost
instantan
destroy
junction
cleft
unusu
enzym
acetylcholinesteras
true
cholinesteras
ach
princip
evid
decay
time
end
plate
current
rapid
diffus
ach
synapt
cleft
would
allow
also
recent
prepar
ach
hydrolyz
nmole
ach
per
mg
protein
per
hour
thu
place
among
enzym
highest
turnov
number
known
power
destruct
capac
reinforc
batteri
butyryl
cholinesteras
pseudo
nonspecif
cholinesteras
destroy
whatev
acetylcholin
may
escap
blood
stream
thu
doubt
whether
acetylcholin
reach
noninnerv
cell
present
extracellular
space
regulatori
concentr
cell
immunolog
signific
antigensensit
lymphocyt
compar
system
rapid
destruct
catecholamin
fact
account
part
widespread
natur
sympathet
action
anoth
way
determin
whether
deal
primari
cholinerg
overact
atopi
examin
whether
evid
enhanc
guanyl
cyclas
activ
cell
obtain
patient
atop
diseas
necessari
sinc
mention
earlier
cholinerg
alphaadrenerg
agent
activ
guanyl
cyclas
markedli
reduc
adenyl
cyclasecycl
amp
respons
betaadrenerg
stimul
shown
present
atop
individu
circumst
highli
signific
avail
evid
show
enhanc
reduc
cholinerg
respons
lymphocyt
atop
individu
thu
found
normal
subject
alphaadrenerg
stimul
norepinephrin
plu
propranolol
cholinerg
stimul
acetylcholin
evok
signific
increas
cyclic
gmp
format
contrast
lymphocyt
guanyl
cyclas
activ
show
signific
respons
agent
patient
acut
asthma
normal
guanyl
cyclas
respons
found
partial
restor
patient
remiss
similarli
lang
goel
greico
studi
adrenerg
cholinerg
respons
peripher
lymphocyt
activ
e
rosett
assay
demonstr
subsensit
lymphocyt
beta
adrenerg
also
cholinerg
stimul
patient
bronchial
asthma
experi
phenylephrin
alphaadrenerg
agonist
show
differ
normal
asthmat
group
enhanc
activ
e
rosett
format
subsensit
beta
adrenerg
cholinerg
system
normal
alpha
adrenerg
effector
system
may
produc
state
rel
enhanc
alpha
adrenerg
activ
circumst
may
explain
find
show
give
alpha
receptor
blocker
one
restor
beta
adrenerg
respons
toward
normal
lymphocyt
asthmat
addit
least
three
major
argument
cholinerg
overact
primari
mechan
atopi
first
neither
pulmonari
sympathectomi
pulmonari
vagotomi
produc
last
improv
bronchial
asthma
second
discuss
detail
elsewher
never
excess
presenc
neurohumor
anyth
prolong
lack
like
result
develop
chronic
effector
hypersensit
consequ
inconceiv
cholinerg
overact
could
produc
hypersensit
acetylcholin
similar
mediat
immedi
hypersensit
contrari
cholinerg
overact
would
expect
lead
desensit
cholinerg
receptor
extens
demonstr
numer
prepar
skelet
muscl
frog
heart
vertebr
invertebr
renshaw
cell
neuron
mollusk
etc
harmoni
recent
find
obtain
nonobstruct
nonrevers
obstruct
revers
obstruct
asthma
patient
use
benzil
stereospecif
radioligand
muscarin
cholinerg
receptor
signific
reduct
receptor
densiti
found
lung
prepar
asthmat
differ
number
receptor
lung
specimen
deriv
nonrevers
obstruct
nonobstruct
group
shown
szentivanyi
et
import
question
cours
one
possibl
find
reduct
number
muscarin
cholinerg
receptor
lung
membran
deriv
patient
revers
obstruct
asthma
simultan
presenc
exquisit
bronchial
hyperreact
cholinerg
agent
time
write
offer
two
possibl
interpret
one
bronchial
hyperreact
cholinerg
agent
asthma
mediat
cholinerg
mechan
basic
due
beta
adrenerg
abnorm
also
respons
atop
featur
diseas
second
possibl
reduct
muscarin
receptor
densiti
caus
heighten
vagu
activ
result
cholinerg
downturn
ultim
produc
pharmacolog
denerv
supersensit
cholinerg
agent
whether
one
interpret
prove
correct
evid
repres
import
evid
valid
nadel
reflex
hypothesi
viral
induc
mechan
bronchoconstrict
asthma
final
atop
state
due
cholinerg
overact
produc
virus
lhrough
postul
reflex
mechan
anticholinerg
agent
far
jemonstr
therapeut
effect
abl
observ
asthma
let
atop
condit
useless
typic
viral
infect
affect
children
atop
dermat
kaposi
herpet
erupt
caus
herp
simplex
type
also
viru
coxsacki
mimic
perfectli
erupt
caus
herpet
viru
virus
associ
diseas
includ
herp
zoster
vaccinia
wart
molluscum
contagiosum
long
known
recurr
viral
cutan
infect
preval
atop
dermat
grow
evid
recurr
cold
sore
upper
respiratori
infect
condit
serolog
studi
also
reveal
atop
dermat
patient
display
significantli
higher
serum
level
antibodi
epstein
barr
viru
ebv
nonatop
control
appear
therefor
increas
suscept
viral
infect
restrict
dermatotrop
virus
rather
reflect
abnorm
host
respons
viral
infect
gener
host
defens
viral
infect
depend
larg
extent
cellmedi
immun
mechan
abund
clinic
experiment
evid
defect
cellmedi
immun
atop
dermat
earli
studi
reduct
number
cell
found
correl
sever
diseas
find
later
complement
demonstr
defect
function
cell
soon
also
shown
cell
defect
particularli
evid
suppressorcytotox
cell
subset
defect
cytotox
cell
also
associ
abnorm
function
macrophag
natur
killer
cell
appear
import
role
impair
host
defens
viral
infect
atop
dermat
sinc
cell
type
produc
capabl
produc
interferon
defici
product
agent
may
least
partli
respons
increas
suscept
viral
infect
atop
dermat
reduc
product
interferon
alpha
children
atop
dermat
well
interferongamma
atop
patient
food
allergi
recent
demonstr
central
immunolog
abnorm
discuss
later
cell
defect
mani
worker
field
appear
primari
inherit
featur
atop
diseas
context
cell
therefor
import
focu
interest
gene
product
primarili
enzym
affect
cell
matur
function
atop
dermat
first
time
report
activ
lymphocyt
cyclic
ampphosphodiesteras
enzym
destroy
cyclic
amp
increas
atop
dermat
well
allerg
respiratori
diseas
adult
increas
activ
correl
close
histamin
releas
basophi
enzymat
activ
togeth
histamin
releas
investig
newborn
use
umbil
cord
blood
signific
elev
phosphodiesteras
activ
reconfirm
newborn
posit
atop
histori
firstdegre
rel
compar
newborn
neg
histori
contrast
adult
howev
correl
phosphodiesteras
activ
histamin
releas
elev
cyclic
amp
phosphodiesteras
activ
cord
blood
leukocyt
develop
clinic
manifest
atopi
strongli
suggest
increas
cyclic
amp
phosphodiesteras
activ
play
primari
role
pathogenesi
atop
diseas
lack
correl
phosphodiesteras
activ
histamin
releas
neonat
suggest
elev
cyclic
amp
phosphodiesteras
activ
primari
genet
link
defect
rather
secondari
vivo
desensit
inflammatori
mediat
histamin
prostaglandin
e
consider
complet
full
circl
core
argument
chapter
guid
us
back
primari
natur
constitut
basi
respiratori
cutan
atop
diseas
follow
public
origin
betaadrenerg
theori
szentivanyi
seri
experi
carri
examin
applic
theori
atop
dermat
studi
peripher
blood
leukocyt
lymphocyt
atop
dermat
frequent
demonstr
impair
beta
adrenerg
reactiv
reveal
loss
regulatori
effect
lysosom
enzym
secret
reduc
format
cyclic
amp
beta
adrenerg
stimul
decreas
affin
bind
radiolabel
betaadrenoceptor
agonist
shift
number
beta
adrenerg
receptor
alpha
adrenerg
receptor
result
increas
ratio
alpha
beta
bind
site
recent
hannifin
made
extens
effort
group
determin
lymphocyt
monocyt
local
alter
adrenerg
receptor
cyclic
amp
respons
cyclic
amp
phosphodiesteras
atop
dermat
experi
number
affin
betaadrenerg
surfac
receptor
mononuclear
leukocyt
subpopul
measur
bind
propranololdisplac
cell
surfac
unfraction
atop
mononuclear
leukocyt
show
reduc
number
beta
adrenerg
receptor
per
cell
togeth
absenc
normal
lower
affin
subpopul
high
affin
beta
receptor
result
linear
scatchard
plot
beta
adrenerg
bind
mononuclearleukocyt
atop
patient
instead
biphas
plot
seen
normal
control
cell
alter
surfac
receptor
cyclic
ampelev
ligand
local
cell
monocyt
patient
atop
dermat
wherea
atop
bcell
receptor
number
affin
ident
normal
bcell
variou
subpopul
tcell
lymphocyt
subset
activat
self
iaantigen
mhcii
bear
present
monocyt
ceil
identifi
radiosensit
function
depend
upon
prolif
step
helperinduc
cell
primari
abnorm
number
andor
intracellular
regul
cyclic
amp
system
radiosensit
helperinduc
tcell
gener
interact
autolog
ia
antigen
present
macrophag
may
explain
mani
characterist
featur
immun
dysfunct
atop
dermat
instanc
solubl
mitogen
stimul
prolifer
critic
depend
success
macrophagetcel
interact
reduc
patient
atop
dermat
develop
pool
blood
pwmrecruit
bcell
vitro
antibodi
product
requir
induct
radiosensit
tcell
induc
inde
bcell
patient
atop
dermat
demonstr
decreas
mitogenstimul
antibodi
secret
even
correct
number
normal
tcell
use
provid
helper
function
tcell
associ
suppressor
cytotox
function
tcell
fcigg
receptor
cell
histamin
hzreceptorbear
tcell
often
show
significantli
reduc
valu
patient
atop
dermat
accord
find
indic
develop
matur
suppressor
cytotox
effector
cell
requir
induct
aforement
radiosensit
thelper
cell
may
ad
develop
cytox
lymphocyt
known
depend
upon
ia
monocyt
stimul
helper
tcell
factor
decreas
product
interleukin
well
interferon
abnorm
helperinduc
tcell
alter
abil
respond
signal
may
explain
reduc
natur
killer
activ
atop
dermat
thu
aforement
multipl
abnorm
cyclic
amp
system
helperinduc
tcell
question
may
account
immun
dysfunct
atop
dermat
altern
immun
abnorm
list
could
due
alter
immun
signal
process
distal
effector
cell
malfunct
intracellular
cyclic
amp
system
point
close
discuss
viral
infect
one
major
development
mechan
betaadrenerg
subsensit
cutan
atopi
need
briefli
revisit
issu
whether
atop
diathesi
increas
suscept
viral
infect
virus
may
produc
atop
disposit
state
demonstr
higher
serum
level
antibodi
ebv
atop
dermat
interpret
support
assumpt
defect
immun
mechan
rather
cutan
alter
predispos
increas
suscept
viral
infect
although
find
rais
ebv
antibodi
titer
atop
dermat
may
fact
reflect
abnorm
host
respons
viru
exclud
caus
effect
relationship
revers
ebv
may
play
caus
role
develop
atop
dermat
thu
ebv
bcell
mitogen
may
stimul
ige
antibodi
format
infecti
mononucleosi
caus
ebv
associ
rais
serum
level
ige
report
case
atop
dermat
develop
soon
episod
infecti
mononucleosi
suggest
ebv
may
fact
occasion
precipit
atop
diseas
essenti
caus
role
viral
agent
describ
respiratori
atopi
allerg
tissu
injuri
anoth
major
development
mechan
betaadrenerg
subsensit
advanc
knowledg
immun
respons
immun
reactiv
achiev
sinc
earli
accompani
complet
understand
differ
pathway
immun
tissu
injuri
base
new
understand
variou
type
immunopatholog
process
subdivid
classif
coomb
cell
follow
four
basic
type
type
immediatehypersensit
type
ii
cytotox
tissu
injuri
type
iii
immunecomplex
tissu
injuri
type
iv
cellmedi
immun
tissu
injuri
classif
oversimplifi
complex
interrelationship
exist
sever
event
constitut
inflammatori
respons
nevertheless
view
repres
closest
approxim
variou
basic
pattern
immun
tissu
injuri
classif
depend
host
speci
method
antigen
exposur
anoth
valuabl
featur
classif
integr
emphasi
import
central
point
variou
pattern
immun
injuri
tissu
damag
result
immun
activ
cellular
biochem
mediat
system
host
combin
immun
reactant
produc
minim
direct
effect
trigger
mechan
set
destruct
factor
play
subject
chapter
gener
pattern
immunolog
tissu
injuri
occur
immedi
hypersensit
discuss
furthermor
distinct
made
atop
nonatop
varieti
immedi
hypersensit
sinc
case
pattern
tissu
injuri
follow
characterist
triphas
reaction
sequenc
manifest
reactiv
follow
initi
antibodi
product
cytotrop
antibodi
primarili
ige
form
dissemin
throughout
circul
becom
almost
select
uniqu
attach
cell
membran
basophil
circul
mast
cell
tissu
attach
occur
structur
area
fc
part
antibodi
molecul
specif
receptor
basophil
mast
cell
membran
although
evid
indic
subpopul
monocyt
macrophag
lymphocyt
also
express
fc
receptor
ige
antibodi
mammalian
cell
basophil
mast
cell
exhibit
extraordinari
bind
affin
antibodi
rel
abund
ige
molecul
bound
along
membran
locat
close
physic
ige
becom
attach
cell
said
sensit
individu
sensit
state
reactiv
subsequ
exposur
antigen
second
subsequ
exposur
occur
via
mani
rout
inhal
ingest
inject
antigen
must
move
across
membran
tissu
barrier
order
come
surfac
sensit
cell
close
encount
occur
antigen
suffici
size
react
antigenbind
site
two
close
adjac
ige
molecul
produc
bridg
effect
molecular
interact
one
antigen
molecul
combin
two
antibodi
molecul
form
bridg
bridg
bring
togeth
two
ige
receptor
molecul
result
coform
chang
receptor
trigger
enzymat
cascad
caus
releas
pharmacolog
activ
effector
molecul
respons
clinic
symptomatolog
immedi
hypersensit
account
pharmacolog
mediat
celltyp
identifi
spectrum
mediatorstor
synthes
transport
cell
includ
neutrophil
leucocyt
slowreact
substanc
anaphylaxi
srsa
eosinophil
chemotact
factor
anaphylaxi
ecfa
enzym
vascular
permeabl
factor
kiningener
substanc
complementactiv
factor
histaminereleas
neutrophil
inhibitori
factor
nif
basophil
leucocyt
histamin
srsa
ecfa
neutrophil
chemotact
factor
ncf
plateletactiv
factor
paf
routin
basophil
leucocyt
histamin
srsa
ecfa
paf
serotonin
eosinophil
leucocyt
histamin
paf
possibl
srsa
mast
cell
histamin
srsa
ecfa
ncf
paf
murin
mast
cell
histamin
srsa
ecfa
paf
ncf
serotonin
chromaffinposit
mast
cell
dopamin
rumin
mammal
possibl
norepinephrin
enterochromaffin
cell
serotonin
chromaffin
cell
catecholamin
platelet
depend
speci
histamin
serotonin
catecholamin
prostaglandin
neurosecretori
cell
histamin
serotonin
catecholamin
acetylcholin
prostaglandin
nerv
cell
potenti
aminemmedi
well
prostaglandin
kinin
collect
hese
pharmacolog
activ
agent
produc
increas
blood
flow
capillari
permeabilti
constrict
smooth
muscl
secret
mucou
gland
manifest
lomin
clinic
pictur
immedi
hypersensit
associ
inflammatori
espons
epend
concentr
experiment
condit
pharmacolog
activ
drenerg
agent
releas
well
inhibit
releas
allerg
mediat
thu
mphetamin
phenylethylamin
tyramin
likesubst
induc
sympathonimet
activ
indirectli
endogen
releas
catecholamin
capabl
iber
histamin
accomplish
exogen
administr
catcholamin
specif
block
agent
agent
elicit
nonimmunolog
listamin
releas
render
sensit
mast
cell
incap
respond
antigen
challeng
vith
histamin
releas
analysi
seemingli
contradictori
find
suggest
adrenerg
agent
interfer
vith
bind
releas
histamin
catecholaminelik
intrins
activ
oper
cellular
system
antigen
activ
thu
central
mechan
f
allerg
reaction
first
conclus
support
residu
agonist
activ
block
agent
mploy
sinc
common
featur
directli
act
adrenerg
compound
pasic
catecholamin
structur
second
conclus
base
observ
methylxnthin
also
inhibit
immunolog
releas
histamin
thu
ragwe
antigen
nade
interact
vitro
ige
antibodi
surfac
leukocyt
ragweedsensi
human
donor
methylxanthin
catecholamin
inhibit
histamin
releas
ignific
find
seen
fact
methylxanthin
competit
inhibitor
specif
phosphodiesteras
inactiv
cyclic
amp
therebi
may
induc
adrenerg
action
increas
intracellular
concentr
compound
inde
cat
cholamin
methylxanthin
found
act
synergist
inhibit
histamin
eleas
phosphodiesteraseinhibitori
potenc
variou
methylxanthin
corel
well
inhibitori
effect
histamin
releas
signific
act
methylxanthin
catecholamin
shown
inhibit
ad
cell
vhen
antigen
present
effect
remov
environ
sensit
ell
antigen
exposur
adenyl
cyclas
system
therefor
must
consid
ls
critic
regulatori
system
allerg
histamin
releas
addit
betaadrenerg
agent
allerg
releas
histamin
pharmacolog
nediat
immedi
hypersensit
also
inhibit
prostaglandin
e
seri
rostacyclin
adenosin
histamin
ie
substanc
interact
cell
membran
eceptor
activ
adenyl
cyclas
inhibit
allerg
mediat
releas
hese
agent
gener
parallel
increas
intracellular
concentr
cyclic
kmp
respect
cell
prepar
furthermor
sinc
releaseinhibitori
activ
hese
agent
block
specif
antagonist
presum
agent
increas
yclic
amp
act
receptor
link
adenyl
cyclas
mechan
cyclic
amp
block
mediat
releas
known
current
evid
suggest
cyclic
amp
act
earli
releas
process
link
obligatori
inward
flux
calcium
relat
microtubul
function
howev
except
chang
cyclic
nucleotid
level
correl
inhibit
immunolog
mediat
releas
natur
dissoci
cyclic
amp
elev
inhibit
unclear
may
explain
function
separ
intracellular
cyclic
amp
pool
product
lipoxygenas
pathway
block
select
biochem
sequenc
link
adenyl
cyclas
activ
inhibit
mediat
releas
effect
chang
intracellular
cyclic
gmp
level
allerg
mediat
releas
less
extens
studi
lung
tissu
alphaadrenerg
cholinerg
stimul
increas
cyclic
gmp
level
effect
well
extracellular
cyclic
gmp
deriv
potenti
antigeninduc
mediat
releas
howev
cyclic
gmp
enhanc
releas
rat
mast
cell
minim
effect
immunolog
mediat
releas
basophil
furthermor
known
whether
cyclic
gmpinduc
enhanc
pulmonari
mediat
releas
direct
effect
alphaadrenerg
cholinerg
agent
mast
cell
whether
reflect
action
cell
type
nevertheless
context
may
ad
pertussi
pharmacolog
establish
betaadrenerg
blockad
report
caus
periton
mast
cell
degranul
rat
mice
wherea
betaadrenerg
stimul
protect
cell
propranolol
induc
degranul
judg
pca
reaction
guinea
pig
propranolol
enhanc
effect
immunolog
mediat
releas
recent
studi
patient
extrins
asthma
anim
model
experiment
asthma
rais
possibl
allerg
tissu
injuri
may
result
develop
form
betaadrenerg
subsensit
studi
devri
et
al
koeter
et
al
patient
complaint
episod
wheez
exposur
allergen
specif
ige
skin
test
increas
bronchial
respons
histamin
inhal
includ
symptom
seven
patient
mild
well
control
without
histori
respiratori
tract
infect
acut
asthmat
attack
two
month
prior
studi
patient
betaadrenerg
corticosteroid
therapi
studi
design
assumpt
might
relationship
allerg
tissu
injuri
adrenerg
system
therefor
latter
studi
inhal
allergen
challeng
two
paramet
measur
vivo
propranolol
threshold
assess
bronchial
betaadrenerg
reactiv
vitro
lymphocyt
camp
product
respons
betaagonist
stimul
propranolol
threshold
chang
percent
challeng
percent
day
patient
maxim
camp
respons
lymphocyt
chang
percent
basal
level
challeng
percent
challeng
recent
develop
beta
subsensit
airway
smooth
muscl
studi
greyhound
dog
order
determin
relationship
hyperreact
airway
aerosol
ascari
suum
antigen
use
thorac
tracheali
smooth
muscl
found
airway
hyperreact
statist
significantli
invers
correl
betaadrenoceptor
densiti
isoproterenol
stimul
camp
product
isoproterenol
stimul
relax
author
conclud
betaadrenerg
subsensit
airway
smooth
muscl
associ
airway
hyperreact
canin
asthma
model
clue
defici
betaadrenoreceptor
sinc
post
receptor
betaadrenerg
respons
measur
came
protein
kinas
relax
tend
depress
anim
airway
hyperreact
studi
clearli
indic
allerg
tissu
injuri
may
one
contributori
factor
develop
betaadrenerg
subsensit
form
human
asthma
altern
sole
factor
subset
human
asthma
may
howev
support
interpret
devri
koeter
et
al
find
suggest
seven
asthmat
studi
betaadrenerg
subsensit
due
endogen
desensit
catecholamin
releas
respons
allerg
tissu
injuri
form
asthma
mechan
respons
manifest
betaadrenerg
subsensit
sever
line
evid
argu
gener
applic
interpret
human
asthma
manifest
atopi
first
endogen
catecholamin
releas
neuron
adren
medullari
catechol
store
would
expect
desensit
alphaand
betaadrenoceptor
less
evenli
forego
studi
alphaadrenoceptor
concentr
sensit
measur
studi
case
thu
pulmonari
homogen
sensit
guinea
pig
expos
chronic
antigen
aerosol
show
signific
increas
alphaadrenoceptor
decreas
betaadrenoceptor
reminisc
reciproc
adrenoceptor
chang
observ
number
human
anim
studi
describ
literatur
alpha
domin
also
reflect
demonstr
alphaadrenerg
agonist
produc
bronchoconstrict
asthmat
patient
normal
subject
similarli
vitro
studi
show
alphareceptor
mediat
constrict
bronchial
smooth
muscl
patient
increas
airway
resist
normal
control
addit
increas
alphaadrenerg
receptor
mediat
respons
vascular
pupillari
smooth
muscl
report
asthmat
furthermor
betaadrenerg
subsensit
asthma
shown
occur
absenc
allerg
symptom
betaadrenerg
medic
circumst
prior
concurr
beta
adrenerg
medic
one
contribut
factor
defect
betaadrenerg
function
also
reflect
presenc
betaadrenerg
subsensit
atop
dermat
betaadrenerg
medic
use
therapeut
modal
nevertheless
endogen
releas
catecholamin
respons
allerg
tissu
injuri
may
contribut
develop
betaadrenerg
subsensit
homolog
desensit
betaadrenerg
receptor
time
endogen
releas
pharmacolog
mediat
ie
histamin
respons
allerg
tissu
injuri
may
contribut
betaadrenerg
subsensit
heterolog
desensit
differ
two
mechan
explain
allerg
tissu
injuri
beta
adrenerg
subsensit
atop
dermat
differ
homolog
heterolog
desensit
result
betaadrenerg
subsensit
could
conveni
explain
model
delean
associ
origin
use
interpret
adrenoceptoradenyl
cyclas
interact
base
larg
extent
ligand
bind
experi
model
envis
three
princip
compon
system
plasma
membran
ie
receptor
r
nucleotidebind
regulatori
protein
n
adenyl
cyclas
c
bind
agonist
receptor
believ
bring
chang
either
promot
stabil
format
ternari
complex
arn
format
complex
promot
dislodg
tightli
bound
guanosin
diphosph
gdp
molecul
n
replac
guanosin
triphosph
gtp
enabl
n
activ
c
thu
stimul
format
came
gtp
subsequ
hydrolyz
gdp
guanosin
triphosphatas
gtpase
associ
n
lead
inactiv
cyclas
three
compon
system
capabl
reactiv
renew
interact
r
agonist
molecul
format
ternari
complex
arn
crucial
import
function
coupl
receptor
cyclas
hypothet
model
antagonist
occupi
receptor
promot
stabil
format
ternari
complex
thu
activ
catalyt
moieti
adenyl
cyclas
biochem
experi
indic
free
form
receptor
r
low
affin
agonist
complex
receptor
plu
nucleotid
protein
rn
high
affin
agonist
chang
receptor
bind
properti
show
lack
high
affin
r
agonist
thu
believ
indic
crucial
arn
complex
form
surprisingli
activ
cyclas
circumst
phenomenon
result
inabl
agoniststimul
betareceptor
activ
adenyl
cyclas
refer
uncoupl
discuss
uncoupl
one
mechan
agonist
induc
desensit
betaadrenerg
receptor
take
place
loss
tissu
respons
agonist
caus
repeat
exposur
agonist
describ
use
varieti
term
includ
desensit
toler
refractori
tachyphylaxi
su
colleagu
divid
phenomena
two
major
categori
heterolog
homolog
desensit
heterolog
desensit
refer
desensit
occur
exposur
cell
biolog
activ
agent
produc
tissu
refractori
varieti
pharmacolog
differ
agonist
contrast
homolog
agonist
specif
desensit
loss
respons
particular
agonist
induc
desensit
specif
group
pharmacolog
relat
agonist
act
tissu
receptor
site
eg
catecholamin
mechan
desensit
produc
complex
variabl
depend
tissu
isoproterenolinduc
desensit
turkey
erythrocyt
appear
fall
categori
heterolog
desensit
loss
sensit
fluorid
ion
gpp
nh
p
less
hydrolyz
analog
substitut
gtp
also
produc
situat
decreas
receptor
number
isoproterenoldesensit
turkey
erythrocyt
rather
appar
uncoupl
betaadrenerg
receptor
adenyl
cyclas
take
place
due
impair
abil
occupi
receptor
form
stabl
highaffin
arn
complex
similar
refractori
produc
exposur
cell
monophosph
camp
analog
suggest
desensit
isoproterenol
caus
agoniststimul
level
camp
within
cell
stadel
cowork
suggest
campdepend
phosphoryl
nucleotid
regulatori
protein
n
may
mechan
desensit
system
thu
alter
receptor
per
se
rather
uncoupl
receptor
adenyl
cyclas
due
modif
nucleotid
regulatori
protein
take
place
exampl
heterolog
desensit
homolog
desensit
betareceptor
observ
number
differ
type
cell
includ
frog
erythrocyt
astrocytoma
cell
produc
agonist
block
antagonist
experi
astrocytoma
cell
shown
betaadrenoceptor
desensit
produc
isoproterenol
involv
least
two
step
earliest
chang
occur
uncoupl
receptor
cyclas
follow
second
step
involv
loss
percent
assay
betareceptor
cell
surfac
recent
studi
catecholaminedesensit
frog
erythrocyt
shown
downregul
unavail
betareceptor
sequest
cytosol
vesicl
apart
guanin
regulatori
protein
catalyt
moieti
adenyl
cyclas
remain
plasma
membran
sequest
receptor
appear
rapidli
degrad
therefor
may
recycl
later
recoveri
tissu
desensit
human
neutrophil
found
undergo
desensit
involv
uncoupl
highli
analog
demonstr
frog
erythrocyt
also
percent
reduct
number
receptor
draw
inform
avail
present
time
one
might
formul
follow
view
heterolog
desensit
betaadrenoceptor
involv
uncoupl
due
impair
abil
receptor
form
highaffin
arn
complex
consequ
activ
adenyl
cyclas
impair
produc
agoniststimul
accumul
camp
within
cell
contrast
homolog
regul
multistep
process
involv
earli
uncoupl
receptor
cyclas
follow
later
intern
uncoupl
receptor
vesicl
understand
return
forego
section
reactiv
mediat
store
cell
antigen
pharmacolog
influenc
relat
cyclic
nucleotid
state
earlier
addit
beta
adrenerg
agent
allerg
releas
histamin
mani
pharmacolog
mediat
immedi
hypersensit
also
inhibit
prostaglandin
e
seri
prostacyclin
adenosin
histamin
ie
substanc
interact
cell
membran
receptor
activ
adenyl
cyclas
normal
physiolog
inhibit
allerg
mediat
releas
agent
kept
check
feedback
effect
respect
receptor
mechan
homolog
heterolog
desensit
atop
diseas
howev
multipl
abnorm
receptoradenyl
cyclaseand
cyclic
amp
system
physiolog
balanc
inhibit
versu
enhanc
mediat
releas
would
expect
lead
exagger
releas
reaction
allerg
tissu
injuri
inde
enhanc
releas
histamin
basophil
mast
cell
shown
occur
atop
dermat
releas
defin
context
capac
mediat
secret
cell
releas
preform
newli
synthes
mediat
among
pharmacolog
mediat
histamin
beststudi
substanc
bestestablish
mechan
igemedi
releas
reaction
first
studi
show
enhanc
antiig
induc
histamin
releas
basophil
perform
lebel
et
al
confirm
ring
associ
last
year
numer
extens
investig
carri
confirm
de
facto
exist
alter
releas
atop
dermat
similarli
increas
releas
histamin
also
found
occur
bronchial
asthma
way
vitro
igesecret
peripher
lymphocyt
might
also
view
form
releas
therefor
import
mention
sever
author
provid
evid
increas
spontan
vitro
igesecret
patient
atop
dermat
analog
gtp
contain
imidodiphosph
rather
pyrophosph
linkag
signific
posit
correl
serum
ige
vitro
ige
secret
also
demonstr
connect
note
although
much
known
ige
regul
rodent
mechan
involv
regul
igesynthesi
man
well
establish
gener
assum
isotyp
specif
suppressor
helper
tcell
play
import
role
relev
subpopul
perhap
fcereceptor
bear
lymphocyt
known
present
furthermor
exact
pathogenet
role
igenreact
atop
dermat
still
controversi
concept
autoantibodi
interact
cell
membran
receptor
hormon
neurotransmitt
could
caus
function
derang
subsequ
diseas
becom
wide
accept
number
diseas
may
mediat
antireceptor
antibodi
rapidli
grow
lead
exampl
diseas
includ
myasthenia
gravi
involv
autoantibodi
direct
nicotin
acetylcholin
receptor
neuromuscular
endplat
grave
diseas
involv
autoantibodi
thyrotropin
receptor
sever
insulin
resist
type
b
insulinresist
diabet
ascrib
autoantibodi
insulin
receptor
thu
forego
diseas
may
view
receptor
diseas
subset
asthma
atop
diseas
may
ultim
recogn
legitim
member
group
inde
describ
autoantibodi
beta
adrenoceptor
identifi
plasma
subject
atop
allergi
although
antibodi
appear
heterogen
share
abil
affect
bind
protein
calf
lung
membran
inhibit
stereospecif
betaadrenerg
radioligand
bind
calf
lung
beta
adrenoceptor
precipit
solubil
calf
lung
betaadrenerg
receptor
indirect
immunoprecipit
assay
furthermor
presenc
autoantibodi
betazadrenoceptor
subject
correl
well
reduc
beta
increas
alphaadrenerg
respons
may
ad
current
avail
materi
even
three
appar
normal
subject
circul
antibodi
significantli
less
respons
betaadrenerg
stimul
remaind
normal
control
precis
frequenc
distribut
autoantibodi
variou
subset
patient
asthma
atop
diseas
current
investig
sever
american
european
laboratori
molecular
mechan
produc
betaadrenerg
subsensit
gener
account
molecular
mechan
involv
develop
autoimmun
gener
reader
refer
analysi
szentivanyi
szentivanyi
orient
chapter
howev
shall
mention
role
viru
infect
developmentalmechan
autoimmun
produc
antireceptor
antibodi
specif
direct
beta
adrenoceptor
thu
viru
infect
elicit
autoantibodi
format
two
mechan
first
viral
antigen
autoantigen
may
becom
associ
form
immunogen
unit
viral
antigen
stimul
host
tlymphocyt
could
function
helper
determin
therebi
stimul
blymphocyt
respons
autoantigen
second
virus
epsteinbarr
viru
ebv
stimul
prolifer
blymphocyt
cell
line
autoantibodi
product
two
way
viral
host
antigen
form
immunogen
unit
host
antigen
incorpor
envelop
virus
viral
antigen
appear
surfac
infect
host
cell
viral
antigen
also
may
form
complex
modifi
histocompat
antigen
membran
constitu
contractil
protein
actin
modifi
viral
antigen
could
stimul
tcell
helper
effect
elicit
autoantibodi
format
human
infect
virus
influenza
measl
varicella
herp
simplex
often
result
autoimmun
manifest
platelet
red
cell
autoantibodi
develop
cold
autoagglutinin
mycoplasma
pneumonia
infect
probabl
occur
tcell
bypass
mechan
follow
infecti
mononucleosi
mani
patient
sera
often
react
sever
autoantigen
includ
autoantibodi
nuclei
lymphocyt
erythrocyt
smooth
muscl
addit
crossreact
heterophil
antibodi
may
note
follow
infecti
mononucleosi
infect
autoantibodi
produc
mechan
similar
observ
alter
selfcompon
viru
bacteria
much
specul
possibl
involv
oncornaviru
pathogenesi
human
system
lupu
erythematosu
